Publication
β2-adrenergic agonists and doping: Where do we stand?
| dc.contributor.author | Lourenço, Olga | |
| dc.contributor.author | Cardoso, Ana Carolina Coelho | |
| dc.contributor.author | Mónico, Beatriz | |
| dc.contributor.author | Gama, Jorge M R | |
| dc.contributor.author | Neiva, H.P. | |
| dc.contributor.author | Marinho, Daniel | |
| dc.date.accessioned | 2021-07-05T11:13:53Z | |
| dc.date.available | 2021-07-05T11:13:53Z | |
| dc.date.issued | 2021-07 | |
| dc.description.abstract | Hostrup et al1 kindly commented on our previous paper related to the enhancement of physical performance by β2-agonists.2 First, we would like to thank the authors for their review and acknowledge that our title and conclusions may have been misleading because, in fact, they only refer to endurance/aerobic-dominated performances [...] | pt_PT |
| dc.description.version | info:eu-repo/semantics/publishedVersion | pt_PT |
| dc.identifier.doi | 10.1111/all.14830 | pt_PT |
| dc.identifier.uri | http://hdl.handle.net/10400.6/11189 | |
| dc.language.iso | eng | pt_PT |
| dc.peerreviewed | yes | pt_PT |
| dc.subject | Doping | pt_PT |
| dc.title | β2-adrenergic agonists and doping: Where do we stand? | pt_PT |
| dc.type | journal article | |
| dspace.entity.type | Publication | |
| oaire.citation.endPage | 2321 | pt_PT |
| oaire.citation.issue | 7 | pt_PT |
| oaire.citation.startPage | 2320-2321 | pt_PT |
| oaire.citation.title | Allergy | pt_PT |
| oaire.citation.volume | 76 | pt_PT |
| person.familyName | Lourenço | |
| person.familyName | Mónico | |
| person.familyName | Reis Gama | |
| person.familyName | Neiva | |
| person.familyName | Marinho | |
| person.givenName | Olga | |
| person.givenName | Beatriz | |
| person.givenName | Jorge Manuel | |
| person.givenName | Henrique | |
| person.givenName | Daniel | |
| person.identifier | 588266 | |
| person.identifier.ciencia-id | 6618-1C4C-D1B7 | |
| person.identifier.ciencia-id | E81F-1C44-F08D | |
| person.identifier.ciencia-id | 8B1F-4EDD-8754 | |
| person.identifier.ciencia-id | 471B-F3CC-479A | |
| person.identifier.orcid | 0000-0002-8401-5976 | |
| person.identifier.orcid | 0000-0003-0653-0478 | |
| person.identifier.orcid | 0000-0003-3926-580X | |
| person.identifier.orcid | 0000-0001-9283-312X | |
| person.identifier.orcid | 0000-0003-2351-3047 | |
| person.identifier.rid | M-5893-2013 | |
| person.identifier.scopus-author-id | 37079568500 | |
| person.identifier.scopus-author-id | 15022568500 | |
| rcaap.rights | openAccess | pt_PT |
| rcaap.type | article | pt_PT |
| relation.isAuthorOfPublication | c890c74a-abc1-4910-aa70-f0da7b4ad902 | |
| relation.isAuthorOfPublication | f26741ac-1535-479f-9a31-0df04f4d78fc | |
| relation.isAuthorOfPublication | 4b605a0e-d32e-4d60-9e39-0290f57c3ff6 | |
| relation.isAuthorOfPublication | 84e6965e-e802-42d2-994e-308b421a167e | |
| relation.isAuthorOfPublication | 1b7a1cda-cf15-4686-bb08-1ac47b66b314 | |
| relation.isAuthorOfPublication.latestForDiscovery | c890c74a-abc1-4910-aa70-f0da7b4ad902 |
Files
Original bundle
1 - 1 of 1
No Thumbnail Available
- Name:
- 2021_Lourenço O_Allergy_Correspondence.pdf
- Size:
- 172.24 KB
- Format:
- Adobe Portable Document Format